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Over the last 25 years, cancer research has produced
an enormous amount of information that has allowed
us to begin to understand the general rules that govern
the transformation of normal cells into malignant
ones. One of the consequences of this knowledge has
been the development of new strategies for drug design
based on new targets whose activity is altered in tumo-
ral cells. The discovery of new tumor markers can help
to improve diagnosis, prognosis and treatment. 
The Spanish Association for Cancer Research (ASEICA)
brings together scientists working in different fields of
cancer research. Our association is very interested in
making new information related to cancer available
to professionals working in different fields of onco-
logy. In order to accomplish this, we plan to publish a
series of articles that will cover, firstly, current know-
ledge of the molecular bases of cell transformation
and, secondly, background information on molecular
biology. We hope that this information will help rea-
ders to understand how this knowledge can be trans-
lated into new tools to help the cancer patient.
MOLECULAR BASIS OF CELL
TRANSFORMATION
Tumorigenesis in humans is a multistep process that
is the result of genetic alterations that contribute to
the progressive transformation of normal cells into
cancer cells. The basic concept in cancer is that tu-
morigenic cells have defects in the regulatory circuits
that control cell proliferation and homeostasis.
Although current information indicates that these cir-
cuits represent a complicated network, all cancer
cells invariably show changes in a discrete and com-
mon group of pathways that dictate malignant
growth. Tumor cells become independent of external
signals for growth by developing autonomous signals
for positive regulation of these pathways. They are in-
sensitive to external signals that inhibit growth or in-
duce differentiation. Tumors develop ways to escape
from the induction of apoptosis, and transformed
cells acquire genetic instability that generates further
genetic alterations. Tumor cells are characterized by
induction of angiogenesis and metastasic potential
and by the acquisition of unlimited replicative poten-
tial (fig. 1).
The order in which these alterations occur in the ge-
neration of tumor cells can vary from one tumor cell
to another; as a consequence, the relative importance
of these changes is very much dependent on the tis-
sue of origin.
MOLECULAR BIOLOGY TECHNIQUES 
USED IN ONCOLOGY
The word «cancer» covers more than 100 different di-
seases, and physicians and cancer researches have 
learned that the more information that can be obtained
in order to perform an accurate estimate of the disea-
se, the more beneficial it will be for the patient. Some-
times, drugs that work for one patient do not work the
same for another patient, even if they have been diagno-
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sed as having the same type of tumor. Additionally, with
the information available at present, it is difficult to
know if a patient will develop resistance to a certain
drug, which makes it difficult to improve clinical results.
With all the new information available and all the
new tools generated by molecular biologists, it will
become possible to draw up molecular profiles for in-
dividual patients and develop individualized therapy.
Some mutations have been related to resistance to
specific drugs, and polymorphisms can be associated
with a different prognosis. Finally, mutations in pro-
teins such as p53 have a different role in drug respon-
se depending on the specific site of the mutation in
the cellular gene. Now researchers have developed a
powerful tool to monitor simultaneously the expres-
sion of thousand of genes within a tumor, based on
microarray technology. This technology has already
been applied to the molecular classification of acute
leukemias. It has been demonstrated that it is possi-
ble to distinguish acute myeloid leukemia from acute
lymphoblastic leukemia without previous biological
knowledge. The technique can also be used to predict
the response of the tumor to different drugs, thus ma-
king chemotherapy more rational. 
In order to make information on this technology avai-
lable to clinical oncologists, we will begin in this arti-
cle by establishing the structural bases of the biologi-
cal material used in these techniques: DNA or RNA. 
The genomes of all organisms are composed of DNA
(deoxyribonucleic acid), and that of some viruses is
composed of RNA (ribonucleic acid). Both types of
molecules are polymers of linear unbranched chains
of monomeric units called nucleotides. Each nucleoti-
de has three components: a phosphate group, a sugar
and a base. If the molecule is DNA, the sugar is 2´-deo-
xyribose, and if it is RNA, the sugar is ribose. For
DNA the bases are adenine (A), cytosine (C), guanine
(G) and thymine (T), and for RNA the fourth base is
uracil (U). Nucleotides are linked to one another by
phosphodiester bonds to form a DNA or RNA polymer
which might be several millions of nucleotides in
length in the case of DNA and no more than a few
thousands for RNA. In the cells, DNA is double stran-
ded and two polynucleotides are wound around one
another to form a double helix. The base components
of the nucleotides form hydrogen bonds that hold to-
gether the double helix in the two strands. The base
pairing is A with T and C with G, making the two
strands complementary. RNA is usually single stran-
ded, although base pairing can occur between some
parts of the single chain (fig. 2).
The biological information contained in the genome
is encoded in the sequence of nucleotides of the DNA
and RNA molecules into units called genes. This in-
formation is read by proteins with enzymatic activity
that attach to the DNA and start a series of biochemi-
cal reactions that are known as gene expression. This
process has two steps, transcription and translation
(fig. 3). Transcription produces a copy of RNA, while
translation, synthesizes a protein whose aminoacid
composition is determined via the genetic code, by
the nucleotide sequence of the transcribed RNA mole-
cule. Each time that a cell divides, a copy of the DNA
is made. This replication of the DNA has to be extre-
mely accurate in order to avoid the introduction of
mutations in the genome. Sometimes, mutations are
installed in the DNA sequence due either to physical
or chemical mutagens or to replication errors. A com-
plicated network of DNA repair enzymatic complexes
repairs the DNA, and defects in expression of these
genes can contribute to the generation of tumor phe-
notype.
The human genome is physically divided in two com-
ponents:
1. The mitochondrial genome, which is a circular
DNA molecule of 16,569 base pairs located in the mi-
tochondria. 
2. The nuclear genome, which comprises approxi-
mately 3 · 109 base pairs of DNA. 
Until the complete sequence of the DNA is known, the
general agreement is that it contains between 80,000
and 100,000 genes. 
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Fig. 2. Complementarity of bases in DNA.
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Other types of elements can also be found within the
human genome:
1. Pseudogenes, are basically a non-functional copy
of a gene that contains a mutation that negatively af-
fects the reading of the information.
2. Repetitive elements, which appear in many places
of the genome, belong to four main groups:
a) LINE: long interspersed nuclear elements.
b) SINE: short interspersed nuclear elements.
c) LTR: long terminal repeats.
d) DNA transposons.
3. Microsatellites contain a short motif repeated in
tandem. Many microsatellites are polymorphic, and
the number of repeats varies among individuals. The-
se elements are useful markers of the genome.
4. Nongenic, nonrepetitive single copy DNA of unknown
function makes up more than 50% of the genome.
Genes are transcribed into an RNA molecule called
messenger RNA, which is translated into a protein.
Two other types of RNA, ribosomal RNA and transfer
RNA, are not translated and have different functions
in the cell.
Each gene has different parts:
1. ORF (open reading frame) is the part of the gene that
codifies for a protein. Each triplet of nucleotides is a co-
don specific for a different aminoacid following the rules
of the genetic code. The ORFs are read in a 5-3´ direc-
tion along the messenger RNA. Each ORF starts in an
initiation codon and finishes in a termination codon.
The part of the messenger RNA located upstream (right
to the 5´of the ORF) of the ORF is called the leader se-
quence and after ORF is the non translated sequence. 
2. Many eucaryotic genes are discontinuous and are
divided into regions called exons (the part of the gene
that codifies for a protein) and introns (the non-codif-
ying region). Introns are processed and eliminated
from the primary or immature RNA, producing a ma-
ture RNA molecule.
References
Genomes TA. Brown. Biosh Sientific Publishers, 1999.
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JA.
Molecular biology of the cell. Garland Publishing Inc, 1994. 
DeVita V, Hellman S, Rosenberg SA. Cancer, principles & prac-
tice in oncology. Philadelphia: JB Lippincott Company, 1995.
